Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

361 results

Coronary, structural and peripheral interventions

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore the latest innovations in coronary, structural, and peripheral interventions in this session, from machine learning CT-FFR systems for severe aortic stenosis to the role of real-world data in enhancing cardiovascular care, and discover cutting-edge techniques like transpedal accesses for complex lesions and comprehensive valve sizing...

Coronary, structural and peripheral interventions

Complex left main scenarios

21 Sep 2023 – From AICT-AsiaPCR 2023

Discover unique insights into these challenging left main scenarios, including anomalous left coronary artery from the pulmonary artery (ALCAPA), guide extension catheter entrapment by a coronary stent, the utility of OCT guidance in complex left main trifurcation PCI, and a rare instance of a young patient with...

Complex left main scenarios

Challenges in calcified lesions

21 Sep 2023 – From AICT-AsiaPCR 2023

Explore a variety of challenging cases in this session, from the perplexing uncrossable STEMI to the specialized "Blocked" balloon anchoring technique, the unique challenges of calcified lesions in elderly patients to the debulking of a calcified nodule within the left circumflex ostium through the stent strut,...

Challenges in calcified lesions

Coronary Atherosclerosis Phenotypes in Focal and Diffuse Disease

16 Aug 2023

This multicenter, prospective, single-arm study determined that Focal CAD had a higher plaque burden and was predominantly lipid-rich with a high prevalence of TCFA, whereas calcifications were more prevalent in diffuse CAD.

Reviewer

Ali Nazmi Calik
Coronary Atherosclerosis Phenotypes in Focal and Diffuse Disease

PCRonline @ ESC Congress 2023: the interventional cardiology perspective!

07 Aug 2023

What was new and hot in interventional cardiology at #ESCCongress 2023!

PCRonline @ ESC Congress 2023

Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation

24 Jul 2023

The aim of the REVASC-TAVI study was to compare different PCI timing strategies in patients with AS and significant CAD undergoing TAVI.

Alessandro Beneduce

Reviewer

Alessandro Beneduce

Reviewer

Omar Alessandro Oliva
Comparison of different percutaneous revascularisation timing strategies in patients undergoing TAVI

The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation

27 Aug 2023

Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial

Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation...

Nicola Ryan

Author

Nicola Ryan
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation

BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial

26 Aug 2023

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Nicola Ryan

Author

Nicola Ryan
BIOFLOW DAPT - Biodegradable polymer SES vs durable polymer ZES in HBR subjects with 1-month DAPT

Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial

12 Jul 2023

This is a trial aiming to assess QFR and 3D-QCA DS% of all the non-infarct related arteries (IRA) with 3D-QCA DS% in all patients presenting with STEMI/NSTEMI and undergoing coronary angiography. 

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag

Reviewer

Jamilah AlRahimi
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial

Should we perform revascularisation in patients with depressed left ventricle ejection fraction?

17 May 2023 – From EuroPCR 2023

Divaka Perera, main author of the REVIVED study, discusses the results of this trial with Flavio Ribichini.

REVIVE was a trial of severe ischaemic cardiomyopathy in which the primary outcome was death or heart failure hospitalization.The headline result was that there was absolutely no difference with PCI,...

Should we perform revascularisation in patients with depressed left ventricle ejection fraction?